Clinical trial

Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to…

NCT00474825 · National Baromedical Services, Other · Completed

Key facts

NCT number NCT00474825
Title Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck
Official title Phase I Clinical Trial of Hyperbaric Oxygen Combined With Radiation and Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Acronym HBO-XRT
Lead sponsor National Baromedical Services, Other
Collaborators Prisma Health-Midlands Mayo Clinic Dartmouth-Hitchcock Medical Center Eastern Virginia Medical School
Status Completed
Phase Phase 1
Study type Interventional
Conditions Carcinoma, Squamous Cell, Cancer of the Head and Neck
Intervention type Drug
Interventions Hyperbaric Oxygen Therapy, Hyperbaric Oxygen, Hyperbaric oxygen
Enrollment 12
Start date Jul 1, 2007
Primary completion Feb 1, 2011
Completion Feb 1, 2011
First posted May 17, 2007
Last update posted Feb 6, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies